Lv11
40 积分 2025-11-21 加入
Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011)
14小时前
求助中
Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma
14小时前
已完结
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
5天前
已完结
Targeting DLL3: Innovative Strategies for Tumor Treatment
5天前
已完结
Heavy-Chain-Only Antibody Expression and B-Cell Development in the Mouse
9个月前
已完结
Reprogramming human B cells with custom heavy-chain antibodies
9个月前
已完结
皖公网安备34019202002308
